About lab
In the current study, we aimed to simulate the GPR30/PI3K/MAPK/STAT signaling pathway in normal and cancer cells by the use of ordinary differential equation modeling. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagerouhimoghadam2018-gpr30-pi3k-mapk-stat-signaling-pathwa-518f2c36
Created2026-05-16
Updated2026-06-13
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsignal-transductionsignalingsystemsbiologytumor-growthvisualisationother
Manifest
{
"io": {
"inputs": [
{
"name": "initial_pegf_egfr2_p_shc_grb2_sos_ras_gdp",
"label": "PEGF EGFR2 pShc Grb2 SOS Ras GDP",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.initial_pegf_egfr2_p_shc_grb2_sos_ras_gdp",
"description": "Initial PEGF EGFR2 pShc Grb2 SOS Ras GDP. Sets the initial value of bundled SBML symbol `mwf40d6176_abfc_4a30_886f_83a19fcffc48`."
},
{
"name": "initial_pegf_egfr2_grb2_sos_ras_gdp",
"label": "PEGF EGFR2 Grb2 SOS Ras GDP",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.initial_pegf_egfr2_grb2_sos_ras_gdp",
"description": "Initial PEGF EGFR2 Grb2 SOS Ras GDP. Sets the initial value of bundled SBML symbol `mw28464aad_8013_4a23_ae09_a406954859a6`."
},
{
"name": "initial_pegf_egfr2_ras_gap",
"label": "PEGF EGFR2 Ras GAP",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.initial_pegf_egfr2_ras_gap",
"description": "Initial PEGF EGFR2 Ras GAP. Sets the initial value of bundled SBML symbol `mwd39388fd_4f85_4d1c_b2a3_37857c595a2d`."
},
{
"name": "initial_pegf_egfr2_ras_gap_ras_gtp",
"label": "PEGF EGFR2 Ras GAP Ras GTP",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.initial_pegf_egfr2_ras_gap_ras_gtp",
"description": "Initial PEGF EGFR2 Ras GAP Ras GTP. Sets the initial value of bundled SBML symbol `mwd7bf31ba_b05c_4c45_bb2f_6a2468a2a507`."
},
{
"name": "initial_pegf_egfr2_ras_gap_shp2",
"label": "PEGF EGFR2 Ras GAP SHP2",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.initial_pegf_egfr2_ras_gap_shp2",
"description": "Initial PEGF EGFR2 Ras GAP SHP2. Sets the initial value of bundled SBML symbol `mwbf5cb039_b830_4282_aa22_a3dda6272ec1`."
},
{
"name": "initial_pp_erk_p_egf_egfr2_p_shc_grb2_sos",
"label": "PpERK pEGF EGFR2 pShc Grb2 SOS",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.initial_pp_erk_p_egf_egfr2_p_shc_grb2_sos",
"description": "Initial PpERK pEGF EGFR2 pShc Grb2 SOS. Sets the initial value of bundled SBML symbol `mw5babe3d5_a9af_4dfd_ac01_35474ef64af2`."
}
],
"outputs": [
{
"name": "pegf_egfr2_p_shc_grb2_sos_ras_gdp",
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.pegf_egfr2_p_shc_grb2_sos_ras_gdp",
"description": "PEGF EGFR2 pShc Grb2 SOS Ras GDP observable. Maps to SBML symbol `mwf40d6176_abfc_4a30_886f_83a19fcffc48`."
},
{
"name": "pegf_egfr2_grb2_sos_ras_gdp",
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.pegf_egfr2_grb2_sos_ras_gdp",
"description": "PEGF EGFR2 Grb2 SOS Ras GDP observable. Maps to SBML symbol `mw28464aad_8013_4a23_ae09_a406954859a6`."
},
{
"name": "pegf_egfr2_ras_gap",
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.pegf_egfr2_ras_gap",
"description": "PEGF EGFR2 Ras GAP observable. Maps to SBML symbol `mwd39388fd_4f85_4d1c_b2a3_37857c595a2d`."
},
{
"name": "pegf_egfr2_ras_gap_ras_gtp",
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.pegf_egfr2_ras_gap_ras_gtp",
"description": "PEGF EGFR2 Ras GAP Ras GTP observable. Maps to SBML symbol `mwd7bf31ba_b05c_4c45_bb2f_6a2468a2a507`."
},
{
"name": "pegf_egfr2_ras_gap_shp2",
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.pegf_egfr2_ras_gap_shp2",
"description": "PEGF EGFR2 Ras GAP SHP2 observable. Maps to SBML symbol `mwbf5cb039_b830_4282_aa22_a3dda6272ec1`."
},
{
"name": "pp_erk_p_egf_egfr2_p_shc_grb2_sos",
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.pp_erk_p_egf_egfr2_p_shc_grb2_sos",
"description": "PpERK pEGF EGFR2 pShc Grb2 SOS observable. Maps to SBML symbol `mw5babe3d5_a9af_4dfd_ac01_35474ef64af2`."
},
{
"name": "state",
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"signal-transduction",
"signaling",
"systemsbiology",
"tumor-growth"
],
"title": "Rouhimoghadam2018 - GPR30/PI3K/MAPK/STAT signaling pathway in normal and cancer cells Lab",
"models": [
{
"path": "models/core",
"alias": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model_state"
],
"from": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.state"
},
{
"to": [
"visualisation.oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model_summary"
],
"from": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model_species_labels"
],
"from": "oncology_sbml_rouhimoghadam2018_gpr30_pi3k_mapk_stat_signaling_model1807040001_model.species_labels"
}
],
"package": "rouhimoghadam2018-gpr30-pi3k-mapk-stat-signaling-pathwa-518f2c36",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.3",
"description": "In the current study, we aimed to simulate the GPR30/PI3K/MAPK/STAT signaling pathway in normal and cancer cells by the use of ordinary differential equation modeling. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.